Traditional biomarkers—estrogen receptor (ER), progesterone receptor (PR), and HER2—retain their prognostic and predictive value in multifocal (MF) and multicentric (MC) breast cancers, as they do in unifocal cases. The gene discussed is ESR1; the disease is breast cancer.